Last 12 months
Inside the activity.
13 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 3 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 5 | 3 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 12, 2026 Filed Oct 13, 2026 21:42 UTC |
HENRY DAVID AChief Financial Officer
|
Tax withholdingCommon Stock | 3,133 | $1.37 | $4,292.21 |
DisclosureSEC source: 0001193125-26-420694 · ownership.xml · nonDerivative · entry 2 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 498,612 F2 · shares: Represents shares sold on October 12, 2026 solely to pay income and other taxes associated with the vesting of RSU's on October 8, 2026, pursuant to an irrevocable election made by the Reporting Party on December 11, 2025 Read SEC document |
| October 12, 2026 Filed Oct 13, 2026 12:30 UTC |
McClure Mary-Katherine HaleChief Commericial Officer
|
GrantCommon Stock | 275,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-419757 · ownership.xml · nonDerivative · entry 1 McClure Mary-Katherine Hale · CIK 0002158031 · Chief Commericial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,000 F1 · shares: Represents a grant of Restricted Stock Units ("RSU's") under an inducement grant approved by the Compensation Committee of the Board of Directors in reliance of an exception granted under Section 711 of the NYSE Amercian Company Guide. 100,000 of these RSU's shall vest on the six-month anniversary of the grant date, 25,000 shall vest on the one year anniversary of the grant date, 125,000 shall vest on the second anniversary of the grant date and the remainder on the third anniversary of the grant date. Read SEC document |
| October 09, 2026 Filed Oct 13, 2026 21:42 UTC |
HENRY DAVID AChief Financial Officer
|
GrantCommon Stock | 6,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-420694 · ownership.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 501,745 F1 · shares: Represents a grant of Restricted Stock Units ("RSU's") under a program approved by the Company's Board of Directors allowing employees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on January 9, 2027 Read SEC document |
| October 09, 2026 Filed Oct 13, 2026 21:39 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
GrantCommon Stock | 8,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-420689 · ownership.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,443,042 F1 · shares: Represents a grant of Restricted Stock Units ("RSU's") under a program approved by the Company's Board of Directors allowing employees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on January 9, 2027 Read SEC document |
| September 11, 2026 Filed Sep 14, 2026 20:30 UTC |
Kovelman HarryChief Medical Officer
|
SaleCommon Stock | 15,488 | $1.27 | $19,683.70 |
DisclosureSEC source: 0001193125-26-390646 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,245 F1 · price: Represents average sales price. Transactions were completed in multiple lots at prices ranging from $1.25 to $1.29 per share. Reporting party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 20:30 UTC |
Morris Milton MayoDirector
|
SaleCommon Stock | 15,000 | $1.41 | $21,150.00 |
DisclosureSEC source: 0001193125-26-383718 · ownership.xml · nonDerivative · entry 1 Morris Milton Mayo · CIK 0001454309 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,391 F1 · price: Sale transaction was completed in a single lot. Read SEC document |
| August 20, 2026 Filed Aug 21, 2026 22:17 UTC |
Kovelman HarryChief Medical Officer
|
SaleCommon Stock | 17,250 | $1.73 | $29,895.98 |
DisclosureSEC source: 0001193125-26-361391 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,983 F1 · price: Represents weighted average sales price. Shares sold in open market transactions in multiple lots at prices ranging from $1.72 to $1.75 per share. Reporting party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 12:08 UTC Amendment |
Kovelman HarryChief Medical Officer
|
SaleCommon Stock | 17,500 | $1.73 | $30,329.25 |
DisclosureSEC source: 0001193125-26-361870 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,733 F1 · price: Represents weighted average sales price. Shares sold in open market transactions in multiple lots at prices ranging from $1.72 to $1.75 per share. Reporting party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 11:54 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
GrantCommon Stock | 146,909 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-343465 · ownership.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,434,679 F1 · shares: Represents a grant of fully vested Restricted Stock Units ("RSU's") as payment for the incentive compensation for the Reporting Party earned for the fiscal year ended December 31, 2025. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 12:07 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 22,457 | $1.42 | $31,888.94 |
DisclosureSEC source: 0001193125-26-343483 · ownership.xml · nonDerivative · entry 2 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,233 F2 · shares: Represents shares withheld solely to pay income and other taxes associated with the aforementioned vesting of RSU's granted on August 7, 2026. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 12:07 UTC |
Kovelman HarryChief Medical Officer
|
GrantCommon Stock | 55,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-343483 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,690 F1 · shares: Represents a grant of fully vested Restricted Stock Units ("RSU's") as payment for incentive compensation for the Reporting Party earned for the fiscal year ended December 31, 2025. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 12:00 UTC |
Mitchell MicahChief Commercial Officer
|
Tax withholdingCommon Stock | 21,559 | $1.42 | $30,613.78 |
DisclosureSEC source: 0001193125-26-343470 · ownership.xml · nonDerivative · entry 2 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,738 F2 · shares: Represents shares withheld solely to pay income and other taxes associated with the aforementioned vesting of RSU's granted on August 7, 2026. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 12:00 UTC |
Mitchell MicahChief Commercial Officer
|
GrantCommon Stock | 58,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-343470 · ownership.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,297 F1 · shares: Represents a grant of fully vested Restricted Stock Units ("RSU's") as payment for incentive compensation for the Reporting Party earned for the fiscal year ended December 31, 2025. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 11:51 UTC |
HENRY DAVID AChief Financial Officer
|
Tax withholdingCommon Stock | 25,310 | $1.42 | $35,940.20 |
DisclosureSEC source: 0001193125-26-343460 · ownership.xml · nonDerivative · entry 2 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 470,163 F2 · shares: Represents shares withheld solely to pay income and other taxes associated with the aforementioned vesting of RSU's granted on August 7, 2026. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 11:51 UTC |
HENRY DAVID AChief Financial Officer
|
GrantCommon Stock | 68,644 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-343460 · ownership.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 495,473 F1 · shares: Represents a grant of fully vested Restricted Stock Units ("RSU's") as payment for incentive compensation for the Reporting Party earned for the fiscal year ended December 31, 2025. Read SEC document |
| July 13, 2026 Filed Jul 13, 2026 20:39 UTC |
HENRY DAVID AChief Financial Officer
|
Tax withholdingCommon Stock | 5,166 | $1.09 | $5,630.94 |
DisclosureSEC source: 0001193125-26-302089 · ownership.xml · nonDerivative · entry 2 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 426,829 F2 · shares: Represents shares sold on July 13, 2026 solely to pay income taxes resulting from the vesting of restricted stock units on July 10, 2026. Transaction was completed pursuant to an irrevocable election made by the Reporting Person on December 11, 2025. Read SEC document |
| July 10, 2026 Filed Jul 13, 2026 20:32 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
GrantCommon Stock | 10,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-302072 · ownership.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,287,770 F1 · shares: Represents a grant of Restricted Stock Units ("RSU's") under a program approved by the Company's Board of Directors allowing employees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on October 10, 2026. Read SEC document |
| July 10, 2026 Filed Jul 13, 2026 20:39 UTC |
HENRY DAVID AChief Financial Officer
|
GrantCommon Stock | 7,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-302089 · ownership.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 431,995 F1 · shares: Represents a grant of Restricted Stock Units ("RSU's") under a program approved by the Company's Board of Directors allowing employees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on October 10, 2026. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 21:11 UTC |
Getz Heather CDirector
|
GrantCommon Stock | 78,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-285696 · ownership.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,458 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in four quarterly installments beginning on September 9, 2026. The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is thirty (30) days following the date of termination of service and (ii) the date of a change in control. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 21:09 UTC |
Morris Milton MayoDirector
|
GrantCommon Stock | 78,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-285681 · ownership.xml · nonDerivative · entry 1 Morris Milton Mayo · CIK 0001454309 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,391 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in four equal quarterly installments beginning September 9, 2026. The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is thirty (30) days following the date of termination of service and (ii) the date of a change in control. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 21:10 UTC |
FEBBO WILLIAM JDirector
|
GrantCommon Stock | 78,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-285686 · ownership.xml · nonDerivative · entry 1 FEBBO WILLIAM J · CIK 0001413987 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,704 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in four equal quarterly installments beginning on September 9, 2026. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 21:12 UTC |
KIRK THOMAS FDirector
|
GrantCommon Stock | 78,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-285703 · ownership.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 772,569 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in four equal quarterly installments beginning September 9, 2026. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 22:04 UTC |
Manko Joseph M. Jr.Director
|
GrantCommon Stock | 78,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001664091-26-000003 · primary_doc.xml · nonDerivative · entry 1 Manko Joseph M. Jr. · CIK 0001664091 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,704 F1 · balance_after: The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is thirty (30) days following the date of termination of service and (ii) the date of a change in control. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 21:13 UTC |
Crowley Thomas Aloysius Jr.Director
|
GrantCommon Stock | 78,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-285705 · ownership.xml · nonDerivative · entry 1 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,452 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in four equal quarterly installments beginning on September 9, 2026. Read SEC document |
| June 12, 2026 Filed Jun 12, 2026 21:06 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 10,442 | $1.20 | $12,530.40 |
DisclosureSEC source: 0001193125-26-269675 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,541 F1 · shares: Represents shares sold on June 12, 2026 solely to pay income taxes resulting from a vesting of restrcted stock units on June 11, 2026, purusant to an irrevocable election made by the Reporting Party on May 28, 2026. Read SEC document |
| June 12, 2026 Filed Jun 12, 2026 20:59 UTC |
Mitchell MicahChief Commercial Officer
|
Tax withholdingCommon Stock | 9,061 | $1.20 | $10,873.20 |
DisclosureSEC source: 0001193125-26-269642 · ownership.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,888 F1 · shares: Represents sale of common stock on June 12, 2026 solely to pay income taxes resulting from a vesting of restricted stock units on June 11, 2026 pursuant to an irrevocable election made on May 28, 2026. Read SEC document |
| June 12, 2026 Filed Jun 12, 2026 20:48 UTC |
HENRY DAVID AChief Financial Officer
|
Tax withholdingCommon Stock | 10,969 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-269607 · ownership.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 424,155 F1 · shares: Represents shares withheld on June 12, 2026 solely to pay income taxes resulting from the vesting of restricted stock units on June 11, 2026. Read SEC document |
| June 08, 2026 Filed Jun 9, 2026 20:38 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 7,635 | $1.33 | $10,154.55 |
DisclosureSEC source: 0001193125-26-263886 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,983 F1 · shares: Represents shares sold on June 8, 2026 solely to pay income taxes resulting from a vesting of restrcted stock units on June 5, 2026. Read SEC document |
| June 08, 2026 Filed Jun 9, 2026 20:44 UTC |
Mitchell MicahChief Commercial Officer
|
Tax withholdingCommon Stock | 6,529 | $1.33 | $8,683.57 |
DisclosureSEC source: 0001193125-26-263916 · ownership.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,949 F1 · shares: Represents sale of common stock on June 8, 2026 solely to pay income taxes resulting from a vesting of restricted stock units on June 5, 2026 pursuant to an irrevocable election made on May 28, 2026. Read SEC document |
| June 08, 2026 Filed Jun 9, 2026 20:11 UTC |
HENRY DAVID AChief Financial Officer
|
Tax withholdingCommon Stock | 10,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-263742 · ownership.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 435,124 F1 · shares: Represents shares withheld on June 8, 2026 solely to pay income taxes resulting from the vesting of restricted stock units on June 5, 2026. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 20:07 UTC |
KIRK THOMAS FDirector
|
PurchaseCommon Stock | 40,002 | $1.27 | $50,802.54 |
DisclosureSEC source: 0001193125-26-263732 · ownership.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 693,865 F1 · shares: Represents open market purchases. F2 · price: Represented weighted average purchase price. Shares were purchased in multiple lots at purchase prices ranging from $1.23 to $1.30 per share. Reporting Party agrees to provide details of the transacitons to the SEC upon request. Read SEC document |
| May 28, 2026 Filed May 29, 2026 01:53 UTC |
Kovelman HarryChief Medical Officer
|
SaleCommon Stock | 11,536 | $1.02 | $11,734.42 |
DisclosureSEC source: 0001193125-26-245953 · ownership.xml · nonDerivative · entry 2 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,618 F1 · shares: Represents open market sale of shares. F3 · price: Represents weighted average sales price. Shares were sold in multiple lots at prices ranging from $1.00 to $1.035 per share. Reporting party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| May 28, 2026 Filed Jun 1, 2026 12:23 UTC |
KIRK THOMAS FDirector
|
PurchaseCommon Stock | 25,000 | $0.99 | $24,825.00 |
DisclosureSEC source: 0001193125-26-249844 · ownership.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 653,863 F1 · shares: Represents open market purchases. F2 · price: Shares were purchased in multiple lots at this purchase price per share. Reporting Party agrees to provide details of the transacitons to the SEC upon request. Read SEC document |
| May 27, 2026 Filed May 29, 2026 01:53 UTC |
Kovelman HarryChief Medical Officer
|
SaleCommon Stock | 20,464 | $1.00 | $20,504.93 |
DisclosureSEC source: 0001193125-26-245953 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,154 F1 · shares: Represents open market sale of shares. F2 · price: Represents weighted average sales price. Shares were sold in multiple lots at prices ranging from $1.00 to $1.005 per share. Reporting party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| May 18, 2026 Filed May 19, 2026 00:20 UTC |
KIRK THOMAS FDirector
|
PurchaseCommon Stock | 43,401 | $0.91 | $39,494.91 |
DisclosureSEC source: 0001193125-26-229323 · ownership.xml · nonDerivative · entry 2 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 628,863 F1 · shares: Represents open market purchases. F3 · price: Represents weighted average purchase price. Shares were purchased in multiple lots at purchase prices ranging from $0.815 to $0.91 per share. Reporting Party agrees to provide details of the transacitons to the SEC upon request. Read SEC document |
| May 15, 2026 Filed May 19, 2026 00:20 UTC |
KIRK THOMAS FDirector
|
PurchaseCommon Stock | 31,605 | $0.91 | $28,747.91 |
DisclosureSEC source: 0001193125-26-229323 · ownership.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 585,462 F1 · shares: Represents open market purchases. F2 · price: Represents weighted average purchase price. Shares were purchased in multiple lots, at purchase prices ranging from $0.9041 to $0.91 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:59 UTC |
Manko Joseph M. Jr.Director
|
PurchaseMYO | 30,367 | $0.89 | $26,959.82 |
DisclosureSEC source: 0001664091-26-000002 · primary_doc.xml · nonDerivative · entry 2 Manko Joseph M. Jr. · CIK 0001664091 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Horton Capital Partners Fund, LP (1) Disclosed balance after: 2,309,775 Read SEC document |
| May 14, 2026 Filed May 18, 2026 20:59 UTC |
Manko Joseph M. Jr.Director
|
PurchaseMYO | 170,830 | $0.86 | $146,947.97 |
DisclosureSEC source: 0001664091-26-000002 · primary_doc.xml · nonDerivative · entry 1 Manko Joseph M. Jr. · CIK 0001664091 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Horton Capital Partners Fund, LP (1) Disclosed balance after: 2,279,408 Read SEC document |
| May 14, 2026 Filed Jun 8, 2026 20:27 UTC Amendment |
Mitchell MicahChief Commercial Officer
|
SaleCommon Stock | 90,231 | $0.86 | $77,688.89 |
DisclosureSEC source: 0001193125-26-261825 · ownership.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,478 F1 · shares: Represents sale of common stock on May 14, 2026 in a series of open market transactions. F2 · price: Represents weighted average sales price. Shares were sold in multiple lots at prices ranging from $0.85 to $0.889 per share. Reporting party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| April 14, 2026 Filed Apr 16, 2026 20:28 UTC |
FEBBO WILLIAM JDirector
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-159101 · ownership.xml · nonDerivative · entry 1 FEBBO WILLIAM J · CIK 0001413987 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 F1 · shares: Represents grant of restricted stock units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's vest in their entirety on the first anniversary of the grant date. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 23:31 UTC |
HENRY DAVID AChief Financial Officer
|
Tax withholdingCommon Stock | 3,953 | $0.71 | $2,806.63 |
DisclosureSEC source: 0001193125-26-155337 · ownership.xml · nonDerivative · entry 2 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 445,174 F2 · shares: Represents shares sold on April 13, 2026 solely to pay income taxes resulting from the vesting of restricted stock units on April 12, 2026. Transaction was conpleted pursuant to an irrevocable election made by the Reporting Party on December 11, 2025. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 23:41 UTC Amendment |
GUDONIS PAUL RDirector · Chief Executive Officer
|
GrantCommon Stock | 16,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-155349 · ownership.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,277,316 F1 · shares: Represents a grant of Restricted Stock Units ("RSU's") under a program approved by the Company's Board of Directors allowing employees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on July 9, 2026. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 23:06 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
GrantCommon Stock | 19,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-155308 · ownership.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,280,045 F1 · shares: Represents a grant of Restricted Stock Units ("RSU's") under a program approved by the Company's Board of Directors allowing employees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on July 9, 2026. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 23:31 UTC |
HENRY DAVID AChief Financial Officer
|
GrantCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-155337 · ownership.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 449,127 F1 · shares: Represents a grant of Restricted Stock Units ("RSU's") under a program approved by the Company's Board of Directors allowing employees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on July 9, 2026. Read SEC document |
| March 16, 2026 Filed Mar 17, 2026 21:39 UTC |
Getz Heather CDirector
|
PurchaseCommon Stock | 20,000 | $0.70 | $13,972.00 |
DisclosureSEC source: 0001193125-26-111290 · ownership.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,754 F1 · shares: Represents open market purchase in a single transaction. Read SEC document |
| March 13, 2026 Filed Mar 16, 2026 22:08 UTC |
KIRK THOMAS FDirector
|
PurchaseCommon Stock | 72,000 | $0.71 | $51,112.80 |
DisclosureSEC source: 0001193125-26-108732 · ownership.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 553,857 F1 · shares: Represents open market purchases. F2 · price: Represents weighted average purchase price. Shares were purchased in multiple lots, at purchase prices ranging from $0.70 to $0.71 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| March 12, 2026 Filed Mar 12, 2026 21:18 UTC |
Getz Heather CDirector
|
PurchaseCommon Stock | 70,000 | $0.73 | $50,960.00 |
DisclosureSEC source: 0001193125-26-104456 · ownership.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,754 F1 · shares: Represents open market purchases. Shares were purchased in multiple lots at prices ranging from $0.72 to $0.73 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request. F2 · price: Represents weighted average purchase price Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:20 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
GrantCommon Stock | 11,637 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-012954 · ownership.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,260,650 F1 · shares: Represents a grant of Restricted Stock Units ("RSU's") under a program approved by the Company's Board of Directors allowing exployees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on April 12, 2026. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:19 UTC |
HENRY DAVID AChief Financial Officer
|
GrantCommon Stock | 8,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-012949 · ownership.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 436,627 F1 · shares: Represents a grant of Restricted Stock Units ("RSU's") under a program approved by the Company's Board of Directors allowing exployees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on April 12, 2026. Read SEC document |
| November 21, 2025 Filed Nov 24, 2025 21:04 UTC |
KIRK THOMAS FDirector
|
PurchaseCommon Stock | 2,535 | $0.72 | $1,825.20 |
DisclosureSEC source: 0001193125-25-293665 · ownership.xml · nonDerivative · entry 2 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 481,857 F1 · shares: Represents open market purchases. F2 · price: Shares were purchased in multiple lots, each executing at $0.72 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.